Press Releases 2013
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra™ Spinal Cord Stimulator System - Dec 06, 2013
New Retrospective Data Presented at NANS 2013 Show Highly Significant Reduction in Pain and High Trial Therapy Success Rate of Precision Spectra in the Treatment of Chronic Pain.
Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine - Jul 19, 2013
Boston Scientific Corporation (NYSE: BSX) has launched a clinical trial to determine whether occipital nerve stimulation (ONS) using the Precision™ System can safely and...
New Survey Finds Chronic Pain Treatments Are Failing Sufferers Across Europe - Jan 29, 2013
Boston Scientific Corporation (NYSE: BSX) today released results of a survey of more than 1,000 chronic pain sufferers across Europe that suggest millions of patients there continue to suffer...